Saturday, July 11, 2026

pharma · Hypovolemia · Pruritus, Chronic Kidney Diseases

Fresenius Kabi Australia

Fresenius Kabi Australia is a pharma organization headquartered in Mount Kuring-Gai, AU. Primary therapeutic focus areas include Hypovolemia, Pruritus, Chronic Kidney Diseases, Chronic inflammatory diseases. NovaPharmaNe

Mount Kuring-Gai, AU HQ
150 Employees
TGA registrant Type
Company details
Status
Public
HQ
Mount Kuring-Gai, AU
Employees
150
Programs
5
Drugs
6
Patents
0
Clinical program

MSB11456

Phase 1 · small molecule · Healthy

MSB11456 for Healthy is a Phase 1 program (small_molecule) at Fresenius Kabi Australia Pty Limited with 1 ClinicalTrials.gov record(s).

Internal code MS200740-0001

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Fresenius Kabi Australia Pty Limited
Phase
Phase 1
Modality
small_molecule
Indication
Healthy
Status
completed
Trials
1

Clinical trials